Live Breaking News & Updates on Affinity Asset Advisors

Stay updated with breaking news from Affinity asset advisors. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Rezolute, Inc. (NASDAQ:RZLT) Sees Large Increase in Short Interest

Rezolute, Inc. (NASDAQ:RZLT – Get Free Report) was the recipient of a large growth in short interest during the month of May. As of May 31st, there was short interest totalling 814,600 shares, a growth of 162.0% from the May 15th total of 310,900 shares. Based on an average daily trading volume, of 571,100 shares, […] ....

United States , Daron Evans , Craig Hallum , Rosalind Advisors Inc , Vanguard Group Inc , Virtu Financial , Acadian Asset Management , Affinity Asset Advisors , Securities Exchange Commission , Rezolute Inc , Maxim Group , Get Free Report , Exchange Commission , Asset Advisors , Asset Management , Rosalind Advisors , Trading Down , Rezolute Daily ,

Kura Oncology (NASDAQ:KURA) Trading Down 4.7%

Kura Oncology, Inc. (NASDAQ:KURA – Get Free Report) dropped 4.7% during trading on Monday . The stock traded as low as $20.43 and last traded at $20.73. Approximately 262,616 shares were traded during mid-day trading, a decline of 77% from the average daily volume of 1,133,167 shares. The stock had previously closed at $21.76. Analyst […] ....

Teresa Brophy Bair , Pricet Rowe Associates Inc , Avoro Capital Advisors , Artal Group , Affinity Asset Advisors , Platinum Investment Management Ltd , Kura Oncology Inc , Kura Oncology , Get Free Report , Capital Advisors , Asset Advisors , Platinum Investment Management , Kura Oncology Daily ,

Point72 Asset Management L.P. Boosts Holdings in Celldex Therapeutics, Inc. (NASDAQ:CLDX)

Point72 Asset Management L.P. raised its holdings in shares of Celldex Therapeutics, Inc. (NASDAQ:CLDX – Free Report) by 105.3% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,756,122 shares of the biopharmaceutical company’s stock after acquiring an additional 1,413,722 shares during the […] ....

New Zealand General , New Zealand , Elizabeth Crowley , Dianec Young , Affinity Asset Advisors , Celldex Therapeutics Inc , Bellevue Group , Exchange Commission , Eventide Asset Management , Celldex Therapeutics , Wellington Management Group , Wolfe Research , Cantor Fitzgerald , Free Report , Capital Management , Management Group , Asset Advisors , Asset Management , Get Free Report , Visit Holdingschannel , Celldex Therapeutics Daily ,

Point72 Asset Management L.P. Acquires 1,413,722 Shares of Celldex Therapeutics, Inc. (NASDAQ:CLDX)

Point72 Asset Management L.P. lifted its holdings in shares of Celldex Therapeutics, Inc. (NASDAQ:CLDX – Free Report) by 105.3% during the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 2,756,122 shares of the biopharmaceutical company’s stock after purchasing an additional 1,413,722 shares during the period. Point72 Asset Management L.P. […] ....

New Zealand General , New Zealand , Elizabeth Crowley , Richardm Wright , Dekabank Deutsche Girozentrale , Wolfe Research , Cantor Fitzgerald , Wellington Management Group , Celldex Therapeutics , Celldex Therapeutics Inc , Charles Schwab Investment Management Inc , Celldex Therapeutics Company Profile , Affinity Asset Advisors , Free Report , Financial Markets , Management Group , Schwab Investment Management , Asset Advisors , Get Free Report , Visit Holdingschannel , Celldex Therapeutics Daily ,

Bellevue Group AG Raises Stock Position in Axsome Therapeutics, Inc. (NASDAQ:AXSM)

Bellevue Group AG increased its stake in Axsome Therapeutics, Inc. (NASDAQ:AXSM – Free Report) by 0.6% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 635,372 shares of the company’s stock after purchasing an additional 3,885 shares during the quarter. Bellevue Group AG owned 1.34% […] ....

United States , Markl Jacobson , Mark Coleman , Robertw Baird , Wealth Group , Affinity Asset Advisors , Royal Bank , Axsome Therapeutics Inc , Exchange Commission , Td Asset Management Inc , Bellevue Group , Lighthouse Investment Partners , Securities Exchange Commission , Axsome Therapeutics , Free Report , Investment Partners , Asset Advisors , Partners Asset Management , Management Inc , Director Mark Coleman , Therapeutics Trading Down , Get Free Report , Axsome Therapeutics Daily ,